A group from WDSrx attended the BioFlorida conference at InVentiv Health in Miami. Keynote speaker Matthew Kim, Founder of Vigilant BioSciences discussed the stages leading to commercialization of the company’s oral cancer screening test. Richard Erwin of Catalyst Pharmaceuticals joined a panel discussion about management issues involved in successful launches. WDSrx supports BioFlorida as part of our strategy for meaningful involvement at every stage of the pharmaceutical 3PL supply chain.
For further information contact WDSrx at info@wdsrx.com or (561) 998-3885.
